Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2026 for Kymera Therapeutics, Inc., €342k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Noah Goodman: trading record in brief
This profile gathers the share dealings of Noah Goodman in Kymera Therapeutics, Inc. We count 3 filings; the first trade dates from 22 June 2026 and the latest from 1 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 1 July 2026, the filings show a transaction worth €342k in Kymera Therapeutics, Inc. Most trades are made public on the day they happen. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Noah Goodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,389 shares@ US$114.670.0040% mcap100.0% of flowCommonSEC144:0001950047-26-006765
5,000 shares@ US$99.87CommonSEC144:0001950047-26-006511
2,500 shares@ US$90.43CommonSEC144:0001950047-26-006382
3 of 3 declarations
